Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 1 , Pages 91-110 , March 2006

Pathways of endocrine disruption during male sexual differentiation and masculinisation

  • Richard M. Sharpe, PhD (Professor, Programme Leader)

      Affiliations

    • Corresponding Author InformationTel.: +44 131 2426387; Fax: +44 131 2426231.

References 

  1. Harley VR, Clarkson MJ, Argentaro A. The molecular action and regulation of the testis-determining factors, SRY (sex-determining region on the Y chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9]. Endocrine Reviews. 2003;24:466–487
  2. Brennan J, Capel B. One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nature Reviews Genetics. 2004;7:509–521
  3. Hughes IA. Minireview: sex differentiation. Endocrinology. 2001;142:3281–3287
  4. Toppari J, Larsen JC, Christiansen P, et al. Male reproductive health and environmental xenoestrogens. Environmental Health Perspectives. 1996;104(supplement 4):741–803
  5. Sharpe RM, Skakkebaek NE. Male reproductive disorders and the role of endocrine disruption: advances in understanding and identification of areas for future research. Pure and Applied Chemistry. 2003;75:2023–2038
  6. Xavier F, Allard S. Anti-Müllerian hormone, beta-catenin and Müllerian duct regression. Molecular and Cellular Endocrinology. 2003;211:115–121
  7. Roberts LM, Visser JA, Ingraham HA. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development. Development. 2002;129:1487–1496
  8. Salva A, Hardy MP, Wu XF, et al. Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation. Biology of Reproduction. 2004;70:600–607
  9. Wu X, Arumugam R, Baker SP, et al. Pubertal and adult Leydig cell function in Müllerian inhibiting substance-deficient mice. Endocrinology. 2005;146:589–595
  10. Gell JS. Müllerian anomalies. Seminars in Reproductive Medicine. 2003;21:375–388
  11. Tsuji M, Shima H, Cunha GR. In vitro androgen-induced growth and morphogenesis of the Wolffian duct within the urogenital ridge. Endocrinology. 1991;128:1805–1811
  12. Sultan C, Paris F, Terouanne B, et al. Disorders linked to insufficient androgen action in male children. Human Reproduction. 2001;7:314–322
  13. Tsuruo Y. Topography and function of androgen-metabolizing enzymes in the central nervous system. Anatomical Science International. 2005;80:1–11
  14. Ellsworth K, Harris G. Expression of the type 1 and 2 steroid 5 alpha-reductases in human fetal tissues. Biochemical and Biophysical Research Communications. 1995;215:774–780
  15. Cohen-Bendahan CC, van de Beek C, Berenbaum SA. Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings. Neuroscience and Biobehavioral Reviews. 2005;29:353–384
  16. Hutchinson JB. Gender-specific steroid metabolism in neural differentiation. Cellular and Molecular Neurobiology. 1997;17:603–626
  17. Sato T, Matsumoto T, Kawano H, et al. Brain masculinization requires androgen receptor function. Proceedings of the National Academy of Sciences of the USA. 2004;101:1673–1678
  18. Garcia-Falgueras A, Pinos H, Collado P, et al. The role of the androgen receptor in CNS masculinization. Brain Research. 2005;1035:13–23
  19. Swaab DF. Sexual differentiation of the human brain: relevance for gender identity, trans-sexualism and sexual orientation. Gynecological Endocrinology. 2004;19:301–312
  20. Gooren LJ, Kruijver FP. Androgens and male behaviour. Molecular and Cellular Endocrinology. 2002;198:31–40
  21. Grumbach MM, Auchus RJ. Estrogen: consequences and implications of human mutations in synthesis and action. The Journal of Clinical Endocrinology and Metabolism. 1999;84:4677–4694
  22. Witorsch RJ. Low-dose in utero effects of xenoestrogens in mice and their relevance to humans: an analytical review of the literature. Food and Chemical Toxicology. 2002;40:905–912
  23. Crescioli C, Maggi M, Vannelli GB, et al. Expression of functional estrogen receptors in human fetal male external genitalia. The Journal of Clinical Endocrinology and Metabolism. 2003;88:1815–1824
  24. Jesmin S, Mowa CN, Matsuda N, et al. Evidence for a potential role of estrogen in the penis: detection of estrogen receptor-alpha and -beta messenger ribonucleic acid and protein. Endocrinology. 2002;143:4764–4774
  25. Brandenberger AW, Tee MK, Lee JY, et al. Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. The Journal of Clinical Endocrinology and Metabolism. 1997;82:3509–3512
  26. Adham IM, Agoulnik AI. Insulin-like 3 signalling in testicular descent. International Journal of Andrology. 2004;27:257–265
  27. Adham IM, Steding G, Thamm T, et al. The overexpression of Insl3 in female mice causes descent of the ovaries. Molecular Endocrinology. 2002;16:244–252
  28. Koskimies P, Suvanto M, Nokkala E, et al. Female mice carrying a ubiquitin promoter-Insl3 transgene have descended ovaries and inguinal hernias but normal fertility. Molecular and Cellular Endocrinology. 2003;206:159–166
  29. Staub C, Rauch M, Ferriere F, et al. Expression of estrogen receptor ESR1 and its 46 kDa variant in the gubernaculum testis. Biology of Reproduction. 2005;73:703–712
  30. George FW. Developmental pattern of 5 alpha-reductase activity in the rat gubernaculum. Endocrinology. 1989;124:727–732
  31. Emmen JM, McLuskey A, Adham IM, et al. Hormonal control of gubernaculum development during testis descent: gubernaculum outgrowth in vitro requires both insulin-like factor and androgen. Endocrinology. 2000;141:4720–4727
  32. Emmen JM, McLuskey A, Adham IM, et al. Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism. Endocrinology. 2000;141:846–849
  33. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction. 2001;16:972–978
  34. Verp MS, Simpson JL. Abnormal sexual differentiation and neoplasia. Cancer Genetics and Cytogenetics. 1987;25:191–218
  35. Toppari J, Kaleva M, Virtanen HE. Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data. Human Reproduction. 2001;7:282–286
  36. Boisen KA, Kaleva M, Main KM, et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet. 2004;363:1264–1269
  37. Hutson JM & Hasthorpe S. Abnormalities of testicular descent. Cell and Tissue Research, in press.
  38. Rutgers JL, Scully RE. The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. International Journal of Gynecological Pathology. 1991;10:126–144
  39. Johnston H, Baker PJ, Abel M, et al. Regulation of Sertoli cell number and activity by follicle-stimulating hormone and androgen during postnatal development in the mouse. Endocrinology. 2004;145:318–329
  40. Tan KAL, De Gendt K, Atanassova N, et al. The role of androgens in Sertoli cell proliferation and functional maturation: studies in mice with total (ARKO) or sertoli cell-selective (SCARKO) ablation of the androgen receptor. Endocrinology. 2005;146:2674–2683
  41. Atanassova N, Walker M, Fisher McKinnell C, et al. Evidence that androgens and oestrogens, as well as FSH, can alter Sertoli cell number in the neonatal rat. The Journal of Endocrinology. 2005;184:107–117
  42. Sharpe RM. Sertoli cell endocrinology and signal transduction: androgen regulation. In Sertoli cell biology. New York: Academic Press, 2005, p. 199–216.
  43. Sharpe RM, McKinnell C, Kivlin C, et al. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction. 2003;125:769–784
  44. Sharpe RM. Regulation of spermatogenesis. In The physiology of reproduction. 2nd ed. New York: Raven Press, 1994, p. 1363–1434.
  45. Storgaard L, Bonde JP, Ernst E, et al. Does smoking during pregnancy affect sons' sperm counts?. Epidemiology. 2003;14:278–286
  46. Jensen TK, Jørgensen N, Punjab M, et al. Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1770 young men from the general population in five European countries. American Journal of Epidemiology. 2004;159:49–58
  47. Barnes-Ellerbe S, Knudsen KE, Puga A. 2,3,7,8-Tetrachlorodibenzo-p-dioxin blocks androgen-dependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation. Molecular Pharmacology. 2004;66:502–511
  48. Kizu R, Okamura K, Toriba A, et al. A role of aryl hydrocarbon receptor in the antiandrogenic effects of polycyclic aromatic hydrocarbons in LNCaP human prostate carcinoma cells. Archives of Toxicology. 2003;77:335–343
  49. Molyneaux K, Wylie C. Primordial germ cell migration. The International Journal of Developmental Biology. 2004;48:537–544
  50. Majdic G, Millar MR, Saunders PT. Immunolocalisation of androgen receptor to interstitial cells in fetal rat testes and to mesenchymal and epithelial cells of associated ducts. Journal of Endourology. 1995;147:285–293
  51. Merchant-Larios H, Moreno-Mendoza N. Mesonephric stromal cells differentiate into Leydig cells in the mouse fetal testis. Experimental Cell Research. 1998;244:230–238
  52. Buehr M, Gu S, McLaren A. Mesonephric contribution to testis differentiation in the fetal mouse. Development. 1993;117:273–281
  53. Vainio S, Heikkila M, Kispert A, et al. Female development in mammals is regulated by Wnt-4 signalling. Nature. 1999;397:405–409
  54. Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, et al. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. The Journal of Pathology. 2003;200:370–374
  55. Barlow NJ, McIntyre BS, Foster PM. Male reproductive tract lesions at 6, 12, and 18 months of age following in utero exposure to di(n-butyl) phthalate. Toxicologic Pathology. 2004;32:79–90
  56. Fisher JS, Macpherson S, Marchetti N, et al. Human ‘testicular dysgenesis syndrome’: a possible model based on in utero exposure of the rat to dibutyl phthalate. Human Reproduction. 2003;18:1383–1394
  57. Mahood IK, McKinnell C, Fisher JS, et al. Abnormal Leydig cell aggregation in the fetal testis of rats exposed to di(n-butyl) phthalate and its possible role in testicular dysgenesis. Endocrinology. 2005;146:613–623
  58. Mahood IK, McKinnell C & Walker M et al. Cellular origins of testicular dysgenesis in rats exposed in utero to di (n-Butyl) phthalate. International Journal of Andrology, in press.
  59. Parks LG, Ostby JS, Lambright CR, et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicological Sciences. 2000;58:339–349
  60. Wilson VS, Lambright C, Furr J, et al. Phthalate ester-induced gubernacular lesions are associated with reduced Insl3 gene expression in the fetal rat testis. Toxicology Letters. 2004;146:207–215
  61. Mylchreest E, Sar M, Cattley RC, et al. Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide. Toxicology and Applied Pharmacology. 1999;156:81–95
  62. Wine RN, Li LH, Barnes LH, et al. Reproductive toxicity of di-n-butylphthalate in a continuous breeding protocol in Sprague-Dawley rats. Environmental Health Perspectives. 1997;105:102–107
  63. Barlow NJ, Foster PMD. Pathogenesis of male reproductive tract lesions from gestation through adulthood following in utero exposure to di(n-butyl) phthalate. Toxicologic Pathology. 2003;31:397–410
  64. Swan SH, Main KM, Liu F, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental Health Perspectives. 2005;113:1056–1061
  65. Gray LE, Ostby J, Furr J, et al. Toxicant-induced hypospadias in the male rat. Advances in Experimental Medicine and Biology. 2004;245:217–241
  66. Haffner SM. Sex hormone-binding protein, hyper-insulinaemia, insulin resistance and noninsulin-dependent diabetes. Hormone Research. 1996;45:233–237
  67. Qian YM, Sun XJ, Tong MH, et al. Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology. 2001;142:5342–5350
  68. Kester MH, Bulduk S, van Toor H, et al. Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. The Journal of Clinical Endocrinology and Metabolism. 2002;87:1142–1150
  69. Kester MH, Bulduk S, Tibboel D, et al. Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology. 2000;141:1587–1589
  70. Rotchell JM, Ostrander GK. Molecular markers of endocrine disruption in aquatic organisms. Journal of Toxicology and Eenvironmental Health Part B Critical Reviews. 2003;6:453–496
  71. Cooke GM. Effect of organotins on human aromatase activity in vitro. Toxicology Letters. 2002;126:121–130
  72. Gray LE, Ostby J, Furr J, et al. Effects of environmental antiandrogens on reproductive development in experimental animals. Human Reproduction Update. 2001;7:248–264
  73. Woodham C, Birch L, Prins GS. Neonatal estrogen down-regulates prostatic androgen receptor through a proteosome-mediated protein degradation pathway. Endocrinology. 2003;144:4841–4850
  74. Prins GS. Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression. Endocrinology. 1992;130:3703–3714
  75. McKinnell C, Atanassova N, Williams K, et al. Suppression of androgen action and the induction of gross abnormalities of the reproductive tract in male rats treated neonatally with diethylstilbestrol. Journal of Andrology. 2001;22:323–338
  76. Rivas A, Fisher JS, McKinnell C, et al. Induction of reproductive tract developmental abnormalities in the male rat by lowering androgen production or action in combination with a low dose of diethylstilbestrol: evidence for importance of the androgen–estrogen balance. Endocrinology. 2003;143:4797–4808

PII: S1521-690X(05)00072-2

doi: 10.1016/j.beem.2005.09.005

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 1 , Pages 91-110 , March 2006

Article Tools

* Image Usage & Resolution